Exact Mass: 465.0954

Exact Mass Matches: 465.0954

Found 114 metabolites which its exact mass value is equals to given mass value 465.0954, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Delphinidin 3-glucoside

5,7-dihydroxy-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-(3,4,5-trihydroxyphenyl)-1lambda4-chromen-1-ylium

[C21H21O12]+ (465.1033)

Delphinidin 3-glucoside is found in adzuki bean. Delphinidin 3-glucoside is isolated from grapes and many other plant species Delphinidin 3-glucoside is present in red wine. Delphinidin 3-glucoside is isolated from grapes and many other plant spp. It is found in red wine, redcurrant, summer grape, strawberry, and green bean. Acquisition and generation of the data is financially supported in part by CREST/JST.

Glucohesperalin

{[(e)-(7-methanesulphinyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulphanyl}heptylidene)amino]oxy}sulphonic acid

C14H27NO10S3 (465.0797)

Glucohesperalin is found in fats and oils. Glucohesperalin is present in seeds of Hesperis matronalis (sweet rocket). Present in seeds of Hesperis matronalis (sweet rocket). Glucohesperalin is found in fats and oils and wasabi.

Tebuquine

3-[(tert-butylamino)methyl]-4-chloro-5-[(7-chloroquinolin-4-yl)amino]-[1,1-biphenyl]-2-ol

C26H25Cl2N3O (465.1375)

Empetrin

Delphinidin 3-O-beta-D-galactopyranoside

C21H21O12 (465.1033)

6-Hydroxycyanidin 3-glucoside

3,5,6,7,3,4-Hexahydroxyflavylium 3-glucoside

C21H21O12 (465.1033)

3-Hydroxy-6-(methylthio)hexyl glucosinolate

C14H27NO10S3 (465.0797)

Delphinidin 3-O-galactoside

C21H21O12 (465.1033)

Delphinidin 7-glucoside

3,5,7,3,4,5-Hexahydroxyflavylium 7-glucoside

C21H21O12 (465.1033)

Bladhianin

3,5,7,3,4,5-Hexahydroxyflavylium 7-galactoside

C21H21O12 (465.1033)

myrtillin

2- (3,4,5-Trihydroxyphenyl) -3- (beta-D-glucopyranosyloxy) -5,7-dihydroxy-1-benzopyrylium

C21H21O12 (465.1033)

N-(2-beta-D-glucopyranosyl-5-hydroxysalicyl)-5-hydroxyanthranilic acid methyl ester

C21H23NO11 (465.1271)

Delphinidin 3-O-glucoside

C21H21O12 (465.1033)

Delphinidin-3-O-beta-glucopyranoside

[C21H21O12]+ (465.1033)

delphinidin-3-glucoside

C21H21O12+ (465.1033)

MMV688350

C24H20N3O4FS (465.1158)

Delphinidin 3-galactoside

C21H21O12 (465.1033)

Delphinidin 3-galactoside

[C21H21O12]+ (465.1033)

Annotation level-1

(Methylsulfinyl)hexyl glucosinolate

C14H27NO10S3 (465.0797)

Annotation level-3

Delphinidin 3-glucoside

[C21H21O12]+ (465.1033)

Annotation level-1

Cys Asp Asp Asn

(3S)-3-[(2R)-2-amino-3-sulfanylpropanamido]-3-{[(1S)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-2-carboxyethyl]carbamoyl}propanoic acid

C15H23N5O10S (465.1166)

Cys Asp Asn Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carboxypropanamido]-3-carbamoylpropanamido]butanedioic acid

C15H23N5O10S (465.1166)

Cys Asn Asp Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-carboxypropanamido]butanedioic acid

C15H23N5O10S (465.1166)

Asp Cys Asp Asn

(3S)-3-[(2R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-sulfanylpropanamido]-3-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}propanoic acid

C15H23N5O10S (465.1166)

Asp Cys Asn Asp

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]butanedioic acid

C15H23N5O10S (465.1166)

Asp Asp Cys Asn

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C15H23N5O10S (465.1166)

Asp Asp Asn Cys

(3S)-3-[(2S)-2-amino-3-carboxypropanamido]-3-{[(1S)-2-carbamoyl-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}ethyl]carbamoyl}propanoic acid

C15H23N5O10S (465.1166)

Asp Asn Cys Asp

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]butanedioic acid

C15H23N5O10S (465.1166)

Asp Asn Asp Cys

(3S)-3-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propanoic acid

C15H23N5O10S (465.1166)

Asn Cys Asp Asp

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-carboxypropanamido]butanedioic acid

C15H23N5O10S (465.1166)

Asn Asp Cys Asp

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanamido]-3-sulfanylpropanamido]butanedioic acid

C15H23N5O10S (465.1166)

Asn Asp Asp Cys

(3S)-3-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanamido]-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propanoic acid

C15H23N5O10S (465.1166)

Glucohesperin

{[(E)-(7-methanesulfinyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}heptylidene)amino]oxy}sulfonic acid

C14H27NO10S3 (465.0797)

An omega-[(methylsulfiny)alkyl]glucosinolic acid in which the omega-(methylsulfinyl)alkyl group is specified as 6-(methylsulfinyl)hexyl.

PyBroP

C12H24BrF6N3P2 (465.0533)

2,2-[[4-[(3,5-dinitro-2-thienyl)azo]phenyl]imino]bisethyl diacetate

C18H19N5O8S (465.0954)

flupyrsulfuron-methyl

C15H14F3N5O7S (465.0566)

JI-101

Urea, N-(1-((2-amino-4-pyridinyl)methyl)-1H-indol-4-yl)-N-(5-bromo-2-methoxyphenyl)-

C22H20BrN5O2 (465.08)

C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor

CVT 10216

C24H19NO7S (465.0882)

CVT-10216 is a highly selective, reversible aldehyde dehydrogenase-2 (ALDH-2) inhibitor with an IC50 of 29 nM. CVT-10216 also has inhibitory effect of ALDH-1 with an IC50 of 1.3 μM. CVT-10216 can reduce excessive alcohol drinking in alcohol-preferring rats and exhibit anxiolytic effects[1].

(S)-Fmoc-beta-Phe(3-Br)-OH

C24H20BrNO4 (465.0576)

Fmoc-(S)-3-Amino-3-(4-bromo-phenyl)-propionic acid

C24H20BrNO4 (465.0576)

(S)-3-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-3-(2-BROMOPHENYL)PROPANOIC ACID

C24H20BrNO4 (465.0576)

(R)-3-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-3-(2-BROMOPHENYL)PROPANOIC ACID

C24H20BrNO4 (465.0576)

5-(METHOXYCARBONYL)-2-PYRIDINECARBOXYLICACID

C17H28N3O8PS (465.1335)

Acid Red 137

C20H18N4NaO6S+ (465.0845)

Fmoc-R-3-Br-PHA

C24H20BrNO4 (465.0576)

Fmoc-D-2-Bromophenylalanine

C24H20BrNO4 (465.0576)

Fmoc-L-2-bromophenylalanine

C24H20BrNO4 (465.0576)

Fmoc-Phe(3-Br)-OH

C24H20BrNO4 (465.0576)

Fmoc-D-Phe(4-Br)-OH

C24H20BrNO4 (465.0576)

Teboquine

C26H25Cl2N3O (465.1375)

C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

METHYL 4-(4-(3-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)UREIDO)PHENOXY)PICOLINATE

C21H15ClF3N3O4 (465.0703)

METHYL 3,4,6-TRI-O-ACETYL-2-DEOXY-2-PHTHALIMIDO-1-THIO-BETA-D-GLUCOPYRANOSIDE

C21H23NO9S (465.1093)

Posizolid

C21H21F2N3O7 (465.1348)

D000890 - Anti-Infective Agents > D023303 - Oxazolidinones C254 - Anti-Infective Agent > C52588 - Antibacterial Agent

(R)-N-Fmoc-3-Bromophenylalanine

C24H20BrNO4 (465.0576)

Fmoc-(R)-3-Amino-3-(4-bromo-phenyl)-propionic acid

C24H20BrNO4 (465.0576)

4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluorobenzoic acid methyl ester

C21H15F4N3O3S (465.077)

(S)-N-Fmoc-4-Bromophenylalanine

C24H20BrNO4 (465.0576)

4-[(2,5-dichlorophenyl)azo]-3-hydroxy-N-(2-methoxyphenyl)naphthalene-2-carboxamide

C24H17Cl2N3O3 (465.0647)

Diphenylpiperidinomethyldioxolan iodide

C22H28INO2 (465.1165)

C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

6-Chloro-N-{(3S)-1-[(1S)-1-methyl-2-(4-morpholinyl)-2-oxo ethyl]-2-oxo-3-pyrrolidinyl}-2-naphthalenesulfonamide

C21H24ClN3O5S (465.1125)

Methyl 2-[[3-(1-benzylpyrazol-4-yl)phenyl]sulfonylamino]-4-fluorobenzoate

C24H20FN3O4S (465.1158)

Delphinidin 3-glucoside

5,7-dihydroxy-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-(3,4,5-trihydroxyphenyl)-1lambda4-chromen-1-ylium

C21H21O12+ (465.1033)

beta-D-Glucopyranose, 1-thio-, 1-[7-(methylsulfinyl)-N-(sulfooxy)heptanimidate]

C14H27NO10S3 (465.0797)

6C-beta-D-glucosyl-2-hydroxyeriodictyol

C21H21O12- (465.1033)

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 4-methylbenzoate

C18H20N5O8P (465.1049)

[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1Z)-7-methylsulfinyl-N-sulfooxyheptanimidothioate

C14H27NO10S3 (465.0797)

N-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]-2-(3-methyl-N-methylsulfonylanilino)acetamide

C24H23N3O3S2 (465.1181)

2-aminobenzoyl-AMP

C17H18N6O8P- (465.0924)

N-(3,4-difluorophenyl)-2-[N-[(3,5-dimethyl-4-isoxazolyl)sulfonyl]-4-ethoxyanilino]acetamide

C21H21F2N3O5S (465.117)

2-(1,3-benzothiazol-2-ylthio)-N-[2-hydroxy-5-(4-morpholinylsulfonyl)phenyl]acetamide

C19H19N3O5S3 (465.0487)

3-(2,4-dimethoxyphenyl)-N-(3-fluoro-4-methylphenyl)-4-oxo-2-sulfanylidene-1H-quinazoline-7-carboxamide

C24H20FN3O4S (465.1158)

3-(Methylsulfamoyl)benzoic acid [2-[(9-ethyl-3-carbazolyl)amino]-2-oxoethyl] ester

C24H23N3O5S (465.1358)

2-[3-(2-furanylmethyl)-2-(4-methoxyphenyl)imino-4-oxo-5-thiazolidinyl]-N-(2-methoxyphenyl)acetamide

C24H23N3O5S (465.1358)

(1S,10S,10aS)-3-(CONH2)-9-Cl-1-(Me2N)-3,3a,4,10-(HO)4-10-Me-2,5-dioxo-1H,10aH,11H,11aH-cyclopenta[b]anthracen-6-olate

C21H22ClN2O8- (465.1065)

5-O-[hydroxy(Phenylacetyl)phosphoryl]adenosine

C18H20N5O8P (465.1049)

3,5-dichloro-N-[2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]ethyl]benzamide

C22H25Cl2N3O4 (465.1222)

3,5-dichloro-N-[2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]ethyl]benzamide

C22H25Cl2N3O4 (465.1222)

3,5-dichloro-N-[2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]ethyl]benzamide

C22H25Cl2N3O4 (465.1222)

3,5-dichloro-N-[2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]ethyl]benzamide

C22H25Cl2N3O4 (465.1222)

3,5-dichloro-N-[2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]ethyl]benzamide

C22H25Cl2N3O4 (465.1222)

3,5-dichloro-N-[2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]ethyl]benzamide

C22H25Cl2N3O4 (465.1222)

3,5-dichloro-N-[2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]ethyl]benzamide

C22H25Cl2N3O4 (465.1222)

3,5-dichloro-N-[2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]ethyl]benzamide

C22H25Cl2N3O4 (465.1222)

6-Hydroxycyanidin 3-glucoside

C21H21O12+ (465.1033)

4-aminobenzoyl-AMP

C17H18N6O8P- (465.0924)

3-O-salicyl-AMP(2-)

C17H16N5O9P-2 (465.0686)

2-acetamido-2-deoxy-3-O-(beta-D-Galp6S)-D-galactitol

C14H27NO14S (465.1152)

[(2R,3R,4S,5S,6R)-2-[(2S,3R,4S,5R)-2-Acetamido-1,4,5,6-tetrahydroxyhexan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl] hydrogen sulfate

C14H27NO14S (465.1152)

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 2-methylbenzoate

C18H20N5O8P (465.1049)

myrtillin

delphinidin 3-O-beta-D-glucopyranoside

C21H21O12+ (465.1033)

Delphinidin 3-O-beta-D-glucoside

C21H21O12 (465.1033)

An anthocyanin cation consisting of delphinidin having a beta-D-glucosyl residue attached at the 3-hydroxy position.

CL 316243

C20H18ClNNa2O7 (465.0567)

CL316243 is a highly potent selective β3-adrenoceptor agonist with a EC50 of 3 nM, but is an extremely poor to β1/2-?receptors[1].CL316243 is a effective stimulant of adipocyte lipolysis and increases brown adipose tissue thermogenesis and metabolic rate[2]. CL316243 has the potential for the treatment obesity, diabetes and urge urinary incontinence[3].